-
Exploring a New FrontierAACR patient advocate forum addresses developments in cancer early detection tests.
by Thomas Celona
-
Forward Look
A New Breast Cancer SubtypeClinical trial results are changing care for people with metastatic breast cancer that expresses low levels of HER2 protein.
by Kris Conner
-
Cancer and AlcoholLowering and increasing alcohol consumption is associated with changes in cancer risk.
by Teresa Bergen
-
Thinking Outside the ClinicResearchers highlight need for outreach and educational programs to address survivorship disparities.
by Thomas Celona
-
Forward Look
Can Understanding Long COVID-19 Teach Us About Chemo Brain?Cognitive effects from COVID-19 and cancer treatment look very similar. Collaboration may lead to better treatment for both.
by Erin O'Donnell
-
Chemo or Not?Tumor profiling tests that predict the likelihood of distant recurrence can help some women with early-stage, hormone receptor-positive breast cancer decide on treatments after surgery.
by Kris Conner
-
Forward Look
Black Patients Less Likely to Receive Targeted RadiationStudy finds racial disparities in the use of proton beam therapy, a focused treatment that can reduce side effects.
by Carolyn Bernhardt
-
Forward Look
Targeting Cancer in KidsNew studies probe how to match targeted therapies to children with cancer.
by Stephen Ornes
-
Forward Look
What’s NextA magnet-guided robot could help doctors look for signs of cancer deeper in the passages of the lungs.
by Darcy Lewis
-
Forward Look
Be Clear About Treatment GoalsPeople with late-stage cancer must ask what they want from treatment.
by Tyler Santora
More than half of patients who participated in a program offering online second opinions were recommended a change to their treatment plan.
by Eric Fitzsimmons
Musical Toxicity an Effect of Cancer TreatmentStudy finding cancer treatment affects ability to play or sing music highlights need for physical therapy, experts say.
by Kyle Bagenstose
Treatment Lags Behind Guidelines for Many Men With Prostate CancerGuidelines for treating advanced prostate cancer changed in 2017, but a recent study indicated many patients were not being treated accordingly.
by Laura Gesualdi Gilmore
Treating HER2-ultralow Breast CancerFDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
